Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...